0001127602-23-026390.txt : 20231031
0001127602-23-026390.hdr.sgml : 20231031
20231031110820
ACCESSION NUMBER: 0001127602-23-026390
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231030
FILED AS OF DATE: 20231031
DATE AS OF CHANGE: 20231031
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oosthuizen Johannes Jacobus
CENTRAL INDEX KEY: 0001916310
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 231362799
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL RD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2023-10-30
0000310158
Merck & Co., Inc.
MRK
0001916310
Oosthuizen Johannes Jacobus
MERCK & CO., INC.
126 EAST LINCOLN AVENUE
RAHWAY
NJ
07065
1
President, U.S. Market
0
Common Stock
2023-10-30
4
M
0
915
102.82
A
20722.657
D
Common Stock
2023-10-30
4
F
0
451
102.82
D
20271.657
D
Restricted Stock Unit
2023-10-30
4
M
0
915
0
D
2021-10-30
2023-10-30
Common Stock
915
0
D
Holdings include shares acquired in dividend reinvestment transactions.
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2021, 10/30/2022 and 10/30/2023.
/s/ Kelly E. W. Grez, as attorney-in-fact for Johannes Oosthuizen
2023-10-31